ScholarIQanswers from OpenAlex & ORCID
Andrew H. Ko
ResearcherPublications, citations & collaboration network
Andrew H. Ko is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrew H. Ko have?
ScholarIQindexed works
Andrew H. Ko has 302 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew H. Ko have?
ScholarIQcitation count
Andrew H. Ko has 17,665 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrew H. Ko?
ScholarIQh-index
Andrew H. Ko has an h-index of 49 in OpenAlex.
What is the i10-index of Andrew H. Ko?
ScholarIQi10-index
Andrew H. Ko has an i10-index of 109 in OpenAlex.
What is the ORCID of Andrew H. Ko?
ScholarIQorcid
The ORCID for Andrew H. Ko is on the source record.
What is the OpenAlex record for Andrew H. Ko?
ScholarIQopenalex
The OpenAlex for Andrew H. Ko is on the source record.
What are the most-cited papers on Andrew H. Ko?
ScholarIQmost cited works
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly, Jaffer A. Ajani, Jarosław Kużdżał, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Méndez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre, Hope E. Uronis, Elena Elimova, Cecile Grootscholten, Karen Geboes, Syed Zafar, Stephanie Snow, Andrew H. Ko, Kynan Feeney, Michael Schenker, Piotr Kocoń, Jenny Zhang, Lili Zhu, Ming Lei, Prianka Singh, Kaoru Kondo, James M. Cleary, Markus Moehler
Pancreatic Adenocarcinoma, Version 2.2014
Margaret A. Tempero, Mokenge P. Malafa, Stephen W. Behrman, Al B. Benson, Ephraim S. Casper, E. Gabriela Chiorean, Vincent Chung, Steven J. Cohen, Brian G. Czito, Anitra Engebretson, Mary Feng, William G. Hawkins, Joseph M. Herman, John P. Hoffman, Andrew H. Ko, Srinadh Komanduri, Albert C. Koong, Andrew M. Lowy, Wen Wee, Nipun B. Merchant, Sean J. Mulvihill, Peter Muscarella, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Sushanth Reddy, Aaron R. Sasson, Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Deborah A. Freedman-Cass
Pancreatic Adenocarcinoma, Version 2.2012
Margaret A. Tempero, J. Pablo Arnoletti, Stephen W. Behrman, Edgar Ben‐Josef, Al B. Benson, Ephraim S. Casper, Steven J. Cohen, Brian G. Czito, Joshua D.I. Ellenhorn, William G. Hawkins, Joseph M. Herman, John P. Hoffman, Andrew H. Ko, Srinadh Komanduri, Albert C. Koong, Wen Wee, Mokenge P. Malafa, Nipun B. Merchant, Sean J. Mulvihill, Peter Muscarella, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Aaron R. Sasson, Anitra Tally, Sarah P. Thayer, Samuel H. Whiting, Robert A. Wolff, Brian M. Wolpin, Deborah A. Freedman-Cass, Dorothy A. Shead
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen, Stefan Buettner, Mustafa Suker, Berend R. Beumer, Pietro Addeo, Philippe Bachellier, Nathan Bahary, Tanios Bekaii‐Saab, Maria Antonietta Bali, Marc G. Besselink, Brian A. Boone, Ian Chau, Stephen Clarke, Mary Dillhoff, Bassel F. El‐Rayes, Jessica M. Frakes, Derek Grose, Peter J. Hosein, Nigel B. Jamieson, Ammar A. Javed, Khurum Khan, Kyu-pyo Kim, Song Cheol Kim, Sunhee S. Kim, Andrew H. Ko, Jill Lacy, Georgios Antonios Margonis, Martin D. McCarter, Colin J. McKay, Eric A. Mellon, Sing Yu Moorcraft, Ken‐ichi Okada, Alessandro Paniccia, Parag J. Parikh, Niek A. Peters, Hans Rabl, Jaswinder S. Samra, Christoph Tinchon, Geertjan van Tienhoven, Eran van Veldhuisen, Andrea Wang‐Gillam, Matthew J. Weiss, Johanna W. Wilmink, Hiroki Yamaue, Marjolein Y.V. Homs, Casper H.J. van Eijck, Matthew H. G. Katz, Bas Groot Koerkamp